Results 301 to 310 of about 2,284,562 (345)
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel +8 more
wiley +1 more source
The influence of "America First" policies on Canada's health security and sovereignty. [PDF]
Simms CD.
europepmc +1 more source
Neuroprotective Effects of Strength Training on Behavioral Deficit, Oxidative Damage, Astrogliosis, and Neuronal Death in a Bipolar Disorder Model. [PDF]
Maidana LM +7 more
europepmc +1 more source
Campolina: a deep neural framework for accurate segmentation of nanopore signals. [PDF]
Bakić S +3 more
europepmc +1 more source
Rethinking cancer care in conflict settings: lessons from Ukraine. [PDF]
Skelton M +3 more
europepmc +1 more source
Entrepreneurship of Young Migrants across Mediterranean Borders
Luisa Mengoni
openalex +1 more source
eHealth competency needs in the Mekong border region: a GLMM analysis of primary care personnel in Nong Khai, Thailand. [PDF]
Kanha S +5 more
europepmc +1 more source
Reigniting the institutional engine for pharmaceutical access: when policy experiments become new global evidence. [PDF]
Chen J, Li W.
europepmc +1 more source

